Evidence for regenerative and biologic therapies varies by product, condition, and clinical setting. Patients deserve a clear explanation of both the evidence and the uncertainty.
What is being studied: selected biologic therapies are being evaluated for some joint and soft-tissue conditions. A research finding for one product or diagnosis should not be generalized to another.
What these therapies are not: a cure-all, a guarantee, or a replacement for an accurate diagnosis. No clinician should promise a specific result.
How we approach it: every regenerative consultation at Dallas Regenex starts with a diagnostic workup. If a biologic option may be reasonable, Dr. Baker explains the current evidence, its limits, and available alternatives—including doing nothing.